Molecular detection and point-of-care testing in Ebola virus disease and other threats: A new global public health framework to stop outbreaks

Expert Review of Molecular Diagnostics

Volumn 15, Issue 10, 2015, Pages 1245-1259

  Kost, Gerald J ^a   Ferguson, William ^a   Truong, Anh Thu ^a   Hoe, Jackie ^a   Prom, Daisy ^a   Banpavichit, Arirat ^a   Kongpila, Surin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ebola; Ebola diagnostic center; emergency use authorization; facilitated access self testing; point ofcare; public health resilience; ultrahigh sensitivity; ultrahigh specificity

Indexed keywords

ARTICLE; EBOLA HEMORRHAGIC FEVER; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EPIDEMIC; HEALTH CARE NEED; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; POINT OF CARE TESTING; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; RISK; SELF EVALUATION; UNITED STATES; CIVIL DEFENSE; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; INTERNATIONAL COOPERATION; KNOWLEDGE BASE; POINT OF CARE SYSTEM; SENSITIVITY AND SPECIFICITY;

CIVIL DEFENSE; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; HUMANS; INTERNATIONAL COOPERATION; KNOWLEDGE BASES; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT-OF-CARE SYSTEMS; SENSITIVITY AND SPECIFICITY;

EID: 84942295482     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2015.1079776     Document Type: Article

References (85)

1. Kost GJ, Louie RF, Curtis CM. Needs assessment for rapid decision making in pandemics, complex emergencies, and disasters: A global perspective Chapter. 43 In: , editor. Kost GJCurtis CM, Assoc. editor. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 3-22
2. Kost GJ, Curtis CM, editor. Global point of care: strategies for disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. Available from: https://www.aacc.org/store/books/9200/global-point-of-care-strategies-fordisastersemergencies-and-public-healthresilience
3. WHO. Urgently needed: rapid, sensitive, safe, and simple Ebola diagnostic tests. November 18, 2014. Available from: www.who.int/mediacentre/news/ebola/18-november-2014-diagnostics/en/[Last accessed 14 July 2015]
4. WHO. Target product profile for zaire ebolavirus rapid, simple test to be used in the control of the Ebola outbreak in West Africa. October 3, 2014. Available from: www.who.int/medicines/publications/targetproduct-profile.pdf?ua=1 [Last accessed 14 July 2015]
5. Kost GJ, Ferguson WJ. Principles of point of care culture, the spatial care path, TM and enabling community and global resilience. Elect J Intl Fed Clin Chem. 2014.25: 4-23. Available from: www.ifcc.org/media/260912/eJIFCC% 20August%202014.pdf [Last accessed 14 July 2015]
6. Kost GJ, Ferguson WJ, Hoe J, et al. The Ebola Spatial Care Path;: Accelerating point-of-care diagnosis, decision making, and community resilience in outbreaks. Am J Disaster Med 2015; in press
7. Kost GJ. Using small-world networks to optimize preparedness, response, and resilience. In: Kost GJ, Curtis CM, editor. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 539-68
8. The World Bank. Ebola: New World bank group study forecasts billions in economic loss if epidemic lasts longer, Spreads in West Africa. Available from: www.worldbank.org/en/news/press-release/2014/10/08/ebola-new-world-bank-group-studyforecasts-billions-in-economic-loss-ifepidemic-lasts-longer-spreads-in-west-africa [Last accessed July 14, 2015]
9. Hospital preparedness: A tiered approach. Available from: www.cdc.gov/vhf/ebola/healthcare-us/preparing/current-treatmentcenters. html [Last accessed August 19, 2015]
10. Kost GJ, Ehrmeyer SS, Chernow B, et al. The laboratory-clinical interface: Point-of-care testing. Chest 1999; 115: 1140-54
11. Kost GJ. Principles and Practice of Point-of-Care Testing. Lippincott Williams and Wilkins, Philadelphia, PA, 2002. p. 654
12. Kost GJ, Sakaguchi A, Curtis C, et al. Enhancing crisis standards of care using innovative point-of-care testing. Am J Disaster Med 2011; 6: 351-68
13. Curtis CM, Louie RF, Vy JH, et al. Innovations in point-of-care testing for United States disaster caches. Am J Disaster Med 2013; 8: 181-204
14. Kost GJ, Curtis C, Louie R, Sakaguchi A. Disaster point-of-care testing: Fundamental concepts and new technologies. In: Arora R, Arora P, editors. Disaster Management: Medical Preparedness, Response, and Homeland Security. CABI International, Wallingford, England, 2013. p. 119-50
15. Kost GJ, Curtis CM, Ferguson WJ, et al. The role of point-of-care testing in complex emergency and disaster resilience. In: Raskovic B, Mrdja S, editors. Natural Disasters: Prevention, Risk Factors and Management. Nova Science Publishers, Hauppauge, New York, 2013. p. 73-110
16. Kost GJ, Curtis CM, Ferguson WJ, et al. Emergency and disaster point-of-care testing in southern Thailand and Phang Nga Province: Tsunami impact, needs assessment, geospatial preparedness, and future resilience. In: Cai T, editor. Tsunamis: Economic Impact, Disaster Management, and Future Resilience. Nova Science Publishers, Hauppauge, New York, 2013. p. 1-39
17. Kost GJ, Curtis CM. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 701
18. Curtis CM, Louie RF, Kost GJ. Current and future design of point of care in national disaster caches. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 413-32
19. Hill CE, Burd EM, Kraft CS, et al. Laboratory test support for Ebola patients within a high-containment facility. Lab Med 2014; 45: e109-11
20. Iwen PC, Garrett JL, Gibbs SG, et al. An integrated approach to laboratory testing for patients with Ebola virus disease. Lab Med 2014; 45: e146-51
21. Walker NF, Brown CS, Youkee D, et al. Evaluation of a point-of-care blood test for identification of Ebola virus disease at Ebola holding units, Western Area, Sierra Leone, January to February 2015. Euro Surveillance 2015; 20 (12): pii 21073
22. Owen WE, Caron JE, Genzen JR. Liver function testing on the Abaxis Piccolo Xpress: Use in Ebola virus disease protocols. Clin Chim Acta 2015; 446: 119-27
23. Kost GJ, Hale KN, Brock TK, et al. Point-of-care testing for disasters: Needs assessment, strategic planning, and future design. Clin Lab Med 2009; 29: 583-05
24. Brock TK, Mecozzi DM, Sumner S, Kost GJ. Evidence-based point-of-care tests and device designs for disaster preparedness. Am J Disaster Med 2010; 5: 285-94
25. Mecozzi DM, Brock TK, Tran NK, et al. Evidence-based point-of-care device design for emergency and disaster care. Point Care 2010; 9: 65-9
26. Kost GJ, Katip P, Curtis CM. Strategic point-of-care requirements of hospitals and public health for preparedness in regions at risk. Point Care 2012; 11: 114-18
27. Kost GJ, Mecozzi DM, Brock TK, Curtis CM. Assessing point-of-care device specifications and needs for pathogen detection in emergencies and disasters. Point Care 2012; 11: 119-25
28. Kost GJ, Katip P, Vinitwatanakhun C. Diagnostic testing strategies for healthcare delivery during the Great Bangkok Flood and other weather disasters. Point Care 2012; 11: 191-9
29. Kost GJ, Katip P, Kulrattanamaneeporn S, Gentile N. Point-of-care testing value proposition for disaster preparedness in small-world networks: Post-tsunami Phang Nga Province, coastal Thailand. Point Care 2013; 12: 9-22
30. PointofCare.net: The point-of-care coordinators online resource, Point-of-care vendors. Available from: www.pointofcare. net/vendors/index.htm [Last accessed 14 July 2015]
31. Centers for disease control and prevention. Clinical laboratory improvements amendments: Waived tests. Available from: wwwn.cdc.gov/clia/Resources/WaivedTests [Last accessed 14 July 2015]
32. Mann PA. Describing a Point-of-care Coordinator's potential role in disasters and complex emergencies. In: Kost GJ, Curtis CM, editors. Global point of care: Strategies for disasters, emergencies, and public health resilience. AACC Press; Washington DC: 2015. p. 347-56
33. Baca JT, Servens V, Lovato D, et al. Rapid detection of Ebola virus with a reagent-free biosensor. Sensors 2015; 15: 8605-14
34. Euler M, Wang Y, Heidenreich D, et al. Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol 2013; 51: 1110-17
35. Yen CW, de Puig H, Tam J, et al. Multicolored silver nanoparticles for multiplexed disease diagnostics: Distinguishing dengue, Yellow fever, and ebola viruses. Lab Chip 2015; 15: 1538-41
36. Saijo M, Niikura M, Ikegamni T, et al. Laboratory diagnostic systems for Ebola and Marburg Hemorrhagic Fevers developed with recombinant proteins. Clin Vaccine Immunol 2006; 13: 444
37. CDC. Ebola (Ebola Virus Disease). Interim Guidance for Specimen Collection, Transport, Testing, and Submission for Persons Under Investigation (PUIs) for Ebola Virus Disease in the United States. Available from: www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimen-collectionsubmission-patients-suspected-infectionebola. html [[Last accessed 31 December 2014]
38. Centers for Disease Control (CDC). Ebola (Ebola Virus Disease). Diagnosis. Available from: www.cdc.gov/vhf/ebola/diagnosis/[Last accessed 14 July 2015]
39. CNN library. Ebola fast facts. Available from: www.cnn.com/2014/04/11/health/ebola-fast-facts/[Last accessed 14 July 2015]
40. BBC News Africa. Ebola: Mapping the outbreak. Available from: www.bbc.com/news/world-africa-28755033 [Last accessed 14 July 2015]
41. Alere i. Available from: http://www.alere-i. com/en/index.html
42. Roche Diagnostics USA. Available from: https://usdiagnostics.roche.com/en/instrument/cobas-liat.html
43. Kost GJ, Katip P, Vansith K, Negash H. The final frontier for point of care: Performance, resilience, and culture. Point Care 2013; 12: 1-8
44. Kost GJ, Zhou Y, Katip P. Understanding point of care culture improves resiliency and standards of care in resource-limited countries. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015; p. 471-90
45. Baker A. Stopping Ebola: The risks and realities of the outbreak-The race to diagnose: Better and faster Ebola testing in West Africa would save lives and could help bring an end to the outbreak. Time 2014; 184: 28-29. Available from: http://timereaders.web.fc2.com/20151b.html [Last accessed 14 July 2015]
46. Kost GJ. Point-of-care testing and public health: A global challenge for the 21st Century. Point Care 2006; 5: 137
47. Young A, Penzenstadler N. 40 Gannett Newspaper Journalists. Biolabs in your backyard: Hundreds of accidents, safety violations and close calls put people at risk. USA Today Weekend 2015; 33 (181): 1A-4A-5A
48. Leonard K. Obama praises ebola vaccine testing, calls for more funding ($6 billion). US. News. December 2, 2014. Available from: www.usnews.com/news/articles/2014/12/02/obama-praises-ebola-vaccine-testingcalls-for-more-funding [Last accessed 14 July 2015]
49. Leonard K. Obama praises ebola vaccine testing, calls for more funding ($6 billion). US. News. December 2, 2014. Available from: www.usnews.com/news/articles/2014/12/02/obama-praises-ebola-vaccine-testingcalls-for-more-funding [Last accessed 14 July 2015]
50. Bissonette L, Bergeron MG. Infectious disease management through point-of-care personalized medicine molecular diagnostic technologies. J Pers Med 2012; 2: 50-70
51. Bissonnette L, Chapdelaine S, Peytavi R, et al. A revolutionary microfluidic stand-alone platform (GenePOC) for nucleic-acid-based point-of-care diagnostics. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 235-48
52. Mahmoudzadeh S, Tran NK, Louie RF, et al. Rapid molecular diagnosis of sepsis in critical, emergency, and disaster care. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 191-220
53. He J, Hoe J. Rapid molecular diagnostics for major respiratory viruses. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 221-34
54. Crowther Z, Powell S. Needs-centered multiplex molecular testing for time-critical infectious diseases. In: , editor. Kost GJ Curtis CM, Assoc. editor. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press. Washington DC: 2015; p. 249-60
55. Sesler C, Green J, Malone L, et al. Target enriched multiplex PCR (TEM-PCRTM) for rapid detection of bloodstream infections. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 261-8
56. Charnot-Katsikas A, Tesic V, Beavis KG. Rapid detection of microorganisms using MALDI-TOF MS in the clinical microbiology laboratory. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 269-76
57. Vandiver TKB. Collaborative medicine: Weaving microbiology into point-of-care clinical responsiveness. In: Kost GJ, Curtis CM, editors. Global Point of Care: Strategies for Disasters, Emergencies, and Public Health Resilience. AACC Press, Washington DC, 2015. p. 277-89
58. Bradsher K. As Ebola spreads, Asia senses vulnerability. International New York Times. October 26, 2014. Available from: www.nytimes.com/2014/10/27/world/asia/as-ebola-spreads-asia-senses-vulnerability.html?-r=0 [Last accessed 14 July 2015]
59. Legacy of SARS leaves Hong Kong better prepared for Ebola fight. South China Morning Post. November 2, 2014. Available from: www.scmp.com/news/hongkong/article/1630457/legacy-sars-leaveshong-kong-better-prepared-ebola-fight [Last accessed 14 July 2015]
60. Macauley R. China is imposing an unofficial Ebola quarantine in its "Little Africa." Quartz. November 26, 2014. Available from: http://qz.com/303070/china-is-imposing-an-unofficial-ebolaquarantine-in-its-little-africa/[Last accessed 14 July 2015]
61. Pifer LLW, Hicks W. Emerging viruses of North America: are labs ready? Medical Laboratory Observer 2015; 47 (3): 10
62. US. Department of Health and Human Services. HHS Launches National Ebola Training and Education Center. July 1, 2015. Available from: www.hhs.gov/news/press/2015pres/07/20150701a.html [Last accessed July 14, 2015]
63. Wahed AAE, Patel P, Heidenriech D, et al. Reverse transcription recombinase polymerase amplification assay for the detection of Middle East Respiratory Syndrome Coronavirus. PLoS Currents 2013; 12: 1-12
64. FDA. 2013 Coronavirus Emergency Use Authorization (Potential Emergency). Available from: www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm#coronavirus [Last accessed 14 July 2015]
65. Park M. South Korea grapples to contain MERS as 1,369 in quarantine. CNN Breaking News. June 3, 2015. Available from: www.cnn.com/2015/06/03/world/south-korea-mers/index.html [Last accessed 14 July 2015]
66. Szabo L. South Korean MERS outbreak likely to spread, health officials say. USA Today. June 3, 2015. Available from: www.usatoday.com/story/news/2015/06/02/mers-spreads-south-korea/28373087/[Last accessed 14 July 2015]
67. Koreans told to "rest easy" over MERS. The Strait Times. July 25, 2015: A14. Available from: www.straitstimes.com/asia/east-asia/koreans-told-to-rest-easy-over-mers [Last accessed 2 August 2015]
68. Developing a qPCR point-of-care diagnostic for Ebola: The Ubiquitome Freedom4 device and PrimeTime®qPCR Assays. Integrated DNA Technologies. July 14, 2015. Available from: http://sg.idtdna.com/pages/decoded/decoded-articles/pcrqpcr/decoded/2015/07/14/developing-aqpcr-point-of-care-diagnostic-for-ebola [Last accessed 2 August 2015]
69. Broadhurst MJ, Kelly JD, Miller A, et al. ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study. Lancet (online first). 2015. Epub ahead of print Available from: http://dx.doi.org/10.1016/S0140-6736(15)61042-X [Last accessed 27 July 2015]
70. WHO. Ebola outbreak-home. Available from: www.who.int/csr/disease/ebola/en
71. WHO. Infection prevention and control guidance for care of patients in health-care settings, with focus on Ebola. Available from: www.who.int/csr/resources/publications/ebola/filovirus-infection-control/en
72. Piccolo Xpress product menu. Available from: www.piccoloxpress.com/products/panels/menu
73. Siemens. CLINITEK Status+ analyzer. Available from: www.healthcare.siemens.com/point-of-care/urinalysis/clinitek-statusanalyzer/technical-specifications
74. Sysmex. pocH-100i™ Automated hematology analyzer. Available from: www.sysmex.com/us/en/Brochures/Brochure-pocH-100i-MKT-10-1025.pdf
75. Piccolo® Liver Panel Plus. Available from: www.piccoloxpress.com/wp-content/uploads/Liver-Panel-Plus.pdf
76. US FDA. Current EUAs. Available from: www.fda.gov/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/MCMLegalRegulatoryandPolicyFramework/ucm182568.htm#current
77. Corgenix. Corgenix and fio combine rapid ebola test with automated analysis and data capture to improve frontline care and case tracking. Available from: www.corgenix. com/news-releases/corgenix-and-fiocombine-rapid-ebola-test-with-automatedanalysis-and-data-capture-to-improvefrontline-care-and-case-tracking/
78. WHO Emergency Quality Assessment Mechanism for EVD IVDs PUBLIC REPORT, Product: RealStar® Filovirus Screen RT-PCR Kit 1.0. Available from: www.who.int/diagnostics-laboratory/procurement/141125-evd-public-report-altona-v1.pdf?ua=1
79. Fierce medical devices, One-hour ebola test from bioMérieux receives FDA emergency use authorization. Available from: www.fiercemedicaldevices.com/story/one-hourebola-test-biom-rieux-receives-fdmergency-use-authorization/2014-10-27
80. Jones A, Boisen M, Radkey R, et al. Development of a multiplex point of care diagnostic for differentiation of Lassa fever, Dengue fever and Ebola hemorrhagic fever. American Association for Clinical Chemistry Poster
81. Nanomix. Discussion of PCR testing and immunoassay testing using the Nanomix system for the detection of Ebola virus. Available from: www.nano.com/downloads/Ebola%20testing-PCR%20vs%20Immunoassay.pdf
82. US FDA. Emergency use authorization. Available from: www.fda.gov/EmergencyPreparedness/Counterterrorism/ucm182568.htm
83. Benzine J, Manna D, Mire C, et al. Rapid point of care molecular diagnostic test for Ebola virus. Poster. 2015, ASM-Biodefense. Available from: www.lucigen.com/docs/posters/ASM-Biodefense-2015-ebola.pdf
84. Johnson M. Lucigen to seek FDA emergency use approval for isothermal Point-of-care ebola test. Available from: www.douglasscientific.com/NewsEvents/News/2014-10-21%20Lucigen%20to% 20Seek%20FDA%20Emergency%20Use% 20Approval%20for%20Isothermal% 20Point-of-Care%20Ebola%20Test.pdf 2014
85. Mangan D. Ebola test: Quick, cheap, easy help in stopping disease. Available from: www.cnbc.com/2015/06/12/ebola-testquick-cheap-easy-help-in-stopping-disease. html 2015